FMCQF - Fresenius Medical Care AG & Co. KGaA

Other OTC - Other OTC Prezzo differito. Valuta in USD.

Fresenius Medical Care AG & Co. KGaA

Else-KrOener-Strasse 1
Bad Homburg 61352
49 6172 609 0

SettoreMedical Care Facilities
Impiegati a tempo pieno125.231

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Ms. Helen GizaCEO, Acting CFO & Chair of Mgmt Board of Fresenius Med. Care Mgmt AG3,44MN/D1968
Dr. Franklin W. Maddux F.A.C.P.Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG2,58MN/D1957
Mr. William J. ValleManagement Board Member for Care Delivery of Fresenius Medical Care Management AG4,21MN/D1960
Dr. Katarzyna Mazur-Hofsab Ph.D.Management Board Member for Care Enablement of Fresenius Medical Care Management AG2,51MN/D1963
Mr. Roberto FusteExec. Advisor for Regional StrategyN/DN/D1952
Dr. Nwamaka Eneanya M.D.Head of Strategy & OperationsN/DN/DN/D
Dr. Dominik HegerExec. VP and Head of Investor Relations, Strategic Devel. & CommunicationsN/DN/DN/D
Mr. Borries Von MullerSr. VP of Global HR Employee CommunicationsN/DN/D1961
Mr. Joachim WeithSr. VP of Corp. Communications & AffairsN/DN/DN/D
Mr. Oliver MaierSr. VP Investor RelationsN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.


Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Governance aziendale

L'ISS Governance QualityScore di Fresenius Medical Care AG & Co. KGaA al 1 giugno 2023 è 7. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 4; diritti degli azionisti: 1; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.